Siga Technologies Inc (SIGA) Stock Price, Quote & News

Company Profile

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. Its lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 212 672 9100

Website: www.siga.com

Address:

31 East 62nd Street, New York, United States

petsaregood71 Jun. 26 at 6:14 PM

$SIGA https://www.linkedin.com/posts/international-biosecurity-and-biosafety-initiative-for-science_activity-7332763871415271424-bxD0

0 · Reply

petsaregood71 Jun. 26 at 5:57 PM

$SIGA https://biodefensecommission.org/wp-content/uploads/2024/05/National-Blueprint-for-Biodefense-2024_final_digital.pdf

0 · Reply

Dostovy Jun. 26 at 4:28 PM

$SIGA We all know how this will end. Approval is imminent, there's no doubt about it, we keep piling up.

0 · Reply

Dostovy Jun. 25 at 5:05 PM

$SIGA This is our golden monkey.

0 · Reply

petsaregood71 Jun. 25 at 4:04 PM

$SIGA everyone wake up --- Could it be that Siga is waiting for the big, beautiful bill to pass for the money --- contract --

1 · Reply

ZacksResearch Jun. 25 at 2:57 PM

$SIGA +16.8% YTD: Can the rally continue? 🧬 $26 million gov’t IV TPOXX order = confidence boost 💵 +$14 million funding = stronger manufacturing 🌍 $6 million intl sale = new market traction ⚠️ Heavy gov’t dependence = policy risk 📦 Pipeline + global demand = upside case Stronger contenders? Watch these 👇 https://www.zacks.com/stock/research/SIGA/industry-comparison?cid=sm-stocktwits-0-comparison_insdustry-oc&ADID=SYND_STOCKTWITS_TWEET_0_COMPARISONINSDUSTRY_OC

0 · Reply

Dostovy Jun. 24 at 9:13 PM

$SIGA https://www.modernghana.com/news/1411069/ghs-cautions-public-against-sex-kiss-other-body.html

0 · Reply

Dostovy Jun. 24 at 9:09 PM

$SIGA https://www.myjoyonline.com/mpox-crisis-71-of-cases-concentrated-in-western-region/

1 · Reply

Dostovy Jun. 24 at 9:08 PM

$SIGA https://www.manilatimes.net/2025/06/22/regions/capiz-logs-first-monkeypox-case/2137358

0 · Reply

ZacksResearch Jun. 20 at 3:12 PM

$SIGA +15.7% YTD: More Upside Ahead? 💉 $70 million TPOXX orders for U.S. stockpile = strong gov’t backing 💰 $62 million already delivered in April + $26 million IV TPOXX in pipeline 🔧 $14 million funding boost for manufacturing resiliency 👶 Pediatric IND filing only H2 '25 = pipeline still early Strong gov’t tailwinds—but clinical ramp still in works. Stronger contenders? Watch these 👇 https://www.zacks.com/stock/research/SIGA/industry-comparison?cid=sm-stocktwits-0-comparison_insdustry-oc&ADID=SYND_STOCKTWITS_TWEET_0_COMPARISONINSDUSTRY_OC

0 · Reply

SIGA Technologies, Inc. (SIGA) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 7 weeks ago

SIGA Reports Financial Results for Three Months Ended March 31, 2025

May 1, 2025, 7:30 AM EDT - 2 months ago

SIGA to Host Business Update Call on May 8, 2025 Following Release of First-Quarter 2025 Results

Apr 8, 2025, 7:30 AM EDT - 2 months ago

SIGA Declares Special Cash Dividend of $0.60 Per Share

Apr 7, 2025, 3:02 AM EDT - 2 months ago

SIGA Technologies: Asymmetric Upside, If 2025 Goes Right

Mar 18, 2025, 7:30 AM EDT - 3 months ago

SIGA Appoints Retired General John M. Keane to its Board of Directors

Mar 11, 2025, 8:55 PM EDT - 3 months ago

SIGA Technologies, Inc. (SIGA) Q4 2024 Earnings Call Transcript

Mar 11, 2025, 4:05 PM EDT - 3 months ago

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2024

Mar 4, 2025, 7:30 AM EST - 4 months ago

SIGA to Host Business Update Call on March 11, 2025 Following Release of Fourth-Quarter and Full Year 2024 Financial Results

Jan 2, 2025, 7:30 AM EST - 6 months ago

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Dec 10, 2024, 4:00 PM EST - 7 months ago

Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced

Dec 2, 2024, 5:49 PM EST - 7 months ago

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

EBS

Nov 21, 2024, 5:01 PM EST - 7 months ago

SIGA Technologies: Expansion Into mAbs Is Smart, But Eggs Remain In One Basket

Nov 8, 2024, 9:18 AM EST - 8 months ago

SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman

Nov 7, 2024, 8:55 PM EST - 8 months ago

SIGA Technologies, Inc. (SIGA) Q3 2024 Earnings Call Transcript

Oct 31, 2024, 7:30 AM EDT - 8 months ago

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

Oct 23, 2024, 8:17 AM EDT - 8 months ago

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating SIGA Technologies, Inc. for potential violations of federal securities laws

Oct 22, 2024, 7:30 AM EDT - 8 months ago

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

Oct 8, 2024, 7:42 AM EDT - 9 months ago

Siga Technologies to supply mpox therapy in Morocco

Oct 8, 2024, 7:30 AM EDT - 9 months ago

SIGA Announces Agreement to Supply TPOXX® in Morocco

Oct 3, 2024, 12:00 PM EDT - 9 months ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Oct 2, 2024, 3:03 PM EDT - 9 months ago

The Law Offices of Frank R. Cruz Announces Investigation of SIGA Technologies, Inc. (SIGA) on Behalf of Investors

Sep 27, 2024, 8:22 AM EDT - 9 months ago

Wolf Haldenstein Adler Freeman & Herz LLP Announces that it is Investigating SIGA Technologies, Inc. for Potential Violations of Federal Securities Laws

Aug 21, 2024, 4:00 PM EDT - 11 months ago

SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

Aug 16, 2024, 2:17 PM EDT - 11 months ago

Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study

Aug 16, 2024, 8:00 AM EDT - 11 months ago

SIGA Technologies: Poised For A Potential Windfall From Monkeypox Emergency Declaration

Aug 15, 2024, 8:36 AM EDT - 11 months ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS GOVX

Aug 15, 2024, 7:35 AM EDT - 11 months ago

Topline Results from PALM 007 Study of SIGA's Tecovirimat in Treatment of Mpox Released

Aug 1, 2024, 9:57 PM EDT - 11 months ago

SIGA Technologies, Inc. (SIGA) Q2 2024 Earnings Call Transcript

Jul 25, 2024, 7:30 AM EDT - 1 year ago

SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results

petsaregood71 Jun. 26 at 6:14 PM

$SIGA https://www.linkedin.com/posts/international-biosecurity-and-biosafety-initiative-for-science_activity-7332763871415271424-bxD0

0 · Reply

petsaregood71 Jun. 26 at 5:57 PM

$SIGA https://biodefensecommission.org/wp-content/uploads/2024/05/National-Blueprint-for-Biodefense-2024_final_digital.pdf

0 · Reply

Dostovy Jun. 26 at 4:28 PM

$SIGA We all know how this will end. Approval is imminent, there's no doubt about it, we keep piling up.

0 · Reply

Dostovy Jun. 25 at 5:05 PM

$SIGA This is our golden monkey.

0 · Reply

petsaregood71 Jun. 25 at 4:04 PM

$SIGA everyone wake up --- Could it be that Siga is waiting for the big, beautiful bill to pass for the money --- contract --

1 · Reply

ZacksResearch Jun. 25 at 2:57 PM

0 · Reply

Dostovy Jun. 24 at 9:13 PM

$SIGA https://www.modernghana.com/news/1411069/ghs-cautions-public-against-sex-kiss-other-body.html

0 · Reply

Dostovy Jun. 24 at 9:09 PM

$SIGA https://www.myjoyonline.com/mpox-crisis-71-of-cases-concentrated-in-western-region/

1 · Reply

Dostovy Jun. 24 at 9:08 PM

$SIGA https://www.manilatimes.net/2025/06/22/regions/capiz-logs-first-monkeypox-case/2137358

0 · Reply

ZacksResearch Jun. 20 at 3:12 PM

0 · Reply

jlonards Jun. 19 at 2:14 PM

$SIGA live now https://x.com/i/broadcasts/1yNxaLpznPNJj?s=09

1 · Reply

jlonards Jun. 18 at 8:40 PM

$SIGA active board.

0 · Reply

geniuscali Jun. 17 at 2:46 PM

$SIGA interesting pricr action.. any positivr news?

0 · Reply

Dostovy Jun. 17 at 2:24 PM

$SIGA The big ones continue shopping.

0 · Reply

Zafather Jun. 17 at 10:42 AM

$SIGA Going to be higher than Shifty at this rate https://www.youtube.com/watch?v=6FEDrU85FLE

0 · Reply

jlonards Jun. 16 at 7:19 PM

$SIGA Trickle up theory

0 · Reply

Dostovy Jun. 16 at 5:23 PM

$SIGA Only the United States and Russia have official stockpiles of smallpox, but the possibility of clandestine stockpiles in countries such as North Korea, China, Iran, Israel, India, or Pakistan.

0 · Reply

Dostovy Jun. 16 at 5:20 PM

$SIGA Tecovirimat is a cornerstone of biodefense against smallpox and other orthopoxviruses, with a solid scientific and regulatory foundation. Its ability to mitigate a smallpox outbreak in a biological warfare context makes it a strategic asset, although its impact would be maximized by combining it with vaccines and epidemiological surveillance. It is an example of proactive preparedness against high-risk biological threats.

0 · Reply

ZacksResearch Jun. 16 at 3:08 PM

$SIGA Gains 18% YTD: More Upside Ahead? 🚀 Tailwinds… but risks remain: 💰 Strong gov’t backing: $26 million IV order + $14 million for long-term manufacturing 🧬 Pipeline advancing: PEP & pediatric programs progressing with FDA/CDC support ⚠️ Heavy reliance on U.S. contracts = recurring revenue risk ⏳ New TPOXX RFP? Timeline still unclear Stronger contenders? Watch these 👇 https://www.zacks.com/stock/research/SIGA/industry-comparison?cid=sm-stocktwits-0-comparison_insdustry-oc&ADID=SYND_STOCKTWITS_TWEET_0_COMPARISONINSDUSTRY_OC

0 · Reply

Lopppendbuffet Jun. 16 at 2:34 PM

$SIGA Moving like a stock that has set the algo’s on buy

0 · Reply

Lopppendbuffet Jun. 13 at 1:33 PM

$SIGA 52k buy when war is breaking out they must know something

1 · Reply

Lopppendbuffet Jun. 13 at 12:51 PM

SIGA Technologies Holds Annual Stockholders Meeting - TipRanks.com $SIGA https://www.tipranks.com/news/company-announcements/siga-technologies-holds-annual-stockholders-meeting

0 · Reply

Market Cap	460.08M
Revenue (ttm)	138.72M
Net Income (ttm)	59.21M
EPS (ttm)	N/A
PE Ratio	9.55
Forward PE	49.23
Profit Margin	42.68%
Debt to Equity Ratio	0.00

Volume	332,300
Avg Vol	469,370
Day's Range	N/A - N/A
Shares Out	71.44M
Stochastic %K	89%
Beta	0.93
Analysts	Strong Buy
Price Target	$11.00